AzTrials
AzTrials

StrokeNCT04658745

Effects of Theta Burst Stimulation on Modulation of Mirror Illusion-induced Rhythm Suppression in Stroke

A study testing Intermittent theta burst stimulation and Mirror Therapy in people with Stroke and Hemiplegia, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to test the hypothesis that rTMS in the form of theta burst stimulation (TBS) over the ipsilateral and contralateral motor cortices can modulate mirror illusion-induced rhythm suppression while observing unilateral arm movement in stroke individuals. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke, Hemiplegia
What is being tested?
Intermittent theta burst stimulation and Mirror Therapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteHong Kong
Study dates
23 Sep 2020to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • type and location of stroke - ischemic or hemorrhagic, cortical or subcortical, confirmed by medical diagnoses compatible with a unilateral lesion involvement;
  • Acute stroke patients: stroke with onset of neurological condition ≤3 months, recruited from a local hospital; Chronic stroke patients: stroke with onset of neurological condition from 6 months to 3 years, recruited from self-help organization in the community. The randomization will be pre-stratified into 2 - subacute and chronic stages, and recruit from 2 centers - acute hospital and self-help organizations in the community.
  • normal or corrected-to-normal visual acuity better than 20/60 (6/18) in the better eye;
  • right-handed, verified by the Edinburgh Handedness Inventory;
  • mild to moderately impaired hemiplegic upper extremity functions, with functional levels 5-7 as rated by the Functional Test for the Hemiplegic Upper Extremity - Hong Kong version (FTHUE-HK);
  • the ability to understand and follow simple verbal instructions;
  • the ability to participate in a therapy session lasting at least 60 minutes; and
  • consent to participate in the study.

Who cannot join

  • prior neurological or psychiatric disorders;
  • severe spasticity (Modified Ashworth Scale >3) over hemiplegic upper extremity;
  • a history of recent Botox injections or acupuncture to the hemiplegic upper extremity within the past three months;
  • use of central nervous system-active medicine;
  • any contraindication to TMS, according to the guideline of the Safety of TMS Consensus group, such as the risk of epilepsy, metal implants, and pregnancy;
  • the presence of unilateral neglect as screened by the Behavioural Inattention Test (CBIT-HK); and
  • participation in another clinical study elsewhere during recruitment. Informed written consent will be obtained from all patients prior to data collection.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Kenneth FONG

    Hong Kong, 000000

Other trials in Hong Kong

About this study

The study aims to test the hypothesis that rTMS in the form of theta burst stimulation (TBS) over the ipsilateral and contralateral motor cortices can modulate mirror illusion-induced rhythm suppression while observing unilateral arm movement in stroke individuals. The investigators further hypothesize that this intervention will lead to the revision of interhemispheric asymmetry. Finally, this study will also explore the longitudinal relationship between rhythm suppression and motor recovery as indicated by motor excitability in the form of MEP. The results of this study will provide significant new information regarding neurophysiological motor relearning mechanisms which could inform the development and evaluation of innovative treatments for individuals with stroke

Read the detailed description

Stroke is the leading cause of physical disability. Facilitating the process of motor relearning would greatly accelerate the rehabilitation of motor functions and elicit positive neuroplasticity of the damaged brain area. Previous research has already explored the feasibility of motor priming techniques embedded in stroke rehabilitation programs using strategies such as non-invasive brain stimulation (NIBS) and mirror therapy (MT). These treatments are usually implemented along with the standardized rehabilitation, sequentially or simultaneously, and have been demonstrated to be more effective than the standardized rehabilitation programs alone.

Mirror neuron, as indicated traditionally by the decrease in the amplitude of Mu rhythm, i.e. a suppression over central electrodes of electroencephalography (EEG), reflects the "seeing" of movement after "perception". Such oscillations are based on neural substrates that are discharged during the observation and execution of a motor act, which is also associated with other human functions, such as imitation, language, etc. The core mirror neuron system (MNS) is thought to be located in the premotor and the primary sensorimotor cortices, indicating that motor learning could be enhanced during action observation and overt movement.

Preliminary research has shown that repetitive Transcranial Magnetic Stimulation (rTMS) can enhance the corticomotor excitability in mirror neurons during both observation of movement (by others) or imagined movement in healthy subjects; in particular, as measured by enhanced motor evoked potentials (MEP). Increases in MEP has also been induced by short-term action observation and mirror visual feedback in stroke survivors. However, it is not yet known if MNS can be activated by TMS in MT following a stroke, and the relationship between mirror neuron activation and clinical improvements in stroke remains unclear.

The investigators have already published preliminary findings in patients with hemiplegic upper extremity, rTMS, and MT. Here, the investigators propose to test the hypothesis that rTMS in the form of theta-burst stimulation (TBS) over the ipsilateral and contralateral motor cortices can modulate mirror illusion-induced rhythm suppression while observing unilateral arm movement in stroke individuals. The investigators further hypothesize that this intervention will lead to the revision of interhemispheric asymmetry. Finally, this study will also explore the longitudinal relationship between rhythm suppression and motor recovery as indicated by motor excitability in the form of MEP. The results of this study will provide significant new information regarding neurophysiological motor relearning mechanisms which could inform the development and evaluation of innovative treatments for individuals with stroke

Conditions
Stroke, Hemiplegia
Being tested
Intermittent theta burst stimulation, Mirror Therapy, Sham intermittent theta burst stimulation, Sham mirror Therapy
Keywords
Stroke, upper extremity, intermittent theta burst stimulation, mirror visual feedback, event-related desynchronization
Medical subject headings
Stroke, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intermittent theta burst stimulationDevice

    iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients, by using a butterfly shape coil.

  • Mirror TherapyBehavioural

    Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

  • Sham intermittent theta burst stimulationDevice

    iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. However, a sham coil will be used, which is not associated with any stimulation effect on the brain.

  • Sham mirror TherapyBehavioural

    In sham mirror therapy, the mirror will be covered. Participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to move the non-affected hand. The participants cannot receive mirror visual feedback of the paretic upper extremity movement during the therapy. Same as mirror therapy, the movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.

Study groups in NCT04658745
Study groupRoleWhat they receive
iTBS over the ipsilesional primary motor cortex plus mirror therapyExperimentaliTBS: iTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. After the iTBS therapy, participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.
Receives: Device: Intermittent theta burst stimulation; Behavioral: Mirror Therapy
Sham iTBS over the ipsilesional primary motor cortex plus mirror therapySham comparatoriTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere, but with a sham coil (i.e., sham iTBS). After the sham stimulation, participants will practice the movements with the non-affected hand and try moving the affected arm at the same time to synchronize with the non-affected hand (illusion on the mirror). The movement practice will involve 5 table-top tasks and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.
Receives: Behavioral: Mirror Therapy; Device: Sham intermittent theta burst stimulation
iTBS to the ipsilesional primary motor cortex plus sham mirror therapySham comparatoriTBS (20 trains of ten bursts at eight-second intervals, 600 stimuli, 200-second per session) will be delivered to the ipsilesional hemisphere in stroke patients. After the iTBS therapy, participants will practice the movements with the non-affected hand and try moving the affected arm at the same time, but with a covered mirror (e.g., sham mirror therapy). In the sham mirror therapy condition, the mirror is covered by a cloth and the participant is instructed to move both arms while looking at a cross mark on the covered mirror and imaging the analogous movements of the affected arm. The movement practice will involve 5 table-top tasks (same as mirror therapy) and the participant will be instructed to perform as many trials as possible in each session with a maximum of 30 trials per task, giving a total of 150 trials per session, lasting for 20 minutes.
Receives: Device: Intermittent theta burst stimulation; Behavioral: Sham mirror Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Measured: Baseline

  2. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Measured: 1 day

  3. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Measured: 2 weeks

  4. Fugl-Meyer assessment (FMA)

    A stroke-specific, performance-based impairment index

    Measured: 1-month after the completion of the intervention

  5. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Measured: Baseline (immediately before the first session)

  6. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Measured: 1 day

  7. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Measured: 2 weeks

  8. Action Research Arm Test (ARAT)

    A measure of upper extremity performance (coordination, dexterity and functioning) in stroke recovery

    Measured: 1-month after the completion of the intervention

Secondary outcomes (16)
  1. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Measured: Baseline (immediately before the first session)

  2. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Measured: 1 day

  3. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Measured: 2 weeks

  4. EEG rhythm power

    Rhythm power desynchronization/synchronization in response to mirror visual feedback

    Measured: 1-month after the completion of the intervention

  5. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

    Measured: Baseline (immediately before the first session)

  6. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

    Measured: 1 day

  7. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex.

    Measured: 2 weeks

  8. Motor-evoked Potential (MEP)

    Electrical potential recorded over a hand muscle, evoked by stimulating the primary motor cortex

    Measured: 1-month after the completion of the intervention

  9. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Measured: Baseline (immediately before the first session)

  10. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Measured: 1 day

  11. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Measured: 2 weeks

  12. Cortical silent period

    The cortical silent period (cSP) refers to an interruption of voluntary muscle activities during contraction by stimulating the contralateral primary motor cortex.

    Measured: 1-month after the completion of the intervention

  13. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Measured: Baseline (immediately before the first session)

  14. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Measured: 1 day

  15. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Measured: 2 weeks

  16. Ipsilateral silent period

    Ipsilateral silent period (iSP) is an interruption of ongoing muscle activities caused by stimulating ipsilateral primary motor cortex.

    Measured: 1-month after the completion of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2020
  2. Study start23 Sep 2020
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04658745
Sponsor's protocol ID
HSEARS20171106002-01
Status last verified
Nov 2020
First submitted
30 Nov 2020
Last updated
2 Feb 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Intermittent theta burst stimulation and Mirror Therapy in people with Stroke and Hemiplegia, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer assessment (FMA) (time frame: Baseline). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in